Preliminary Trial of SNA014 for Pancreatic Cancer

A Study of FG-M108+Chemotherapy vs Placebo+Chemotherapy in Claudin18.2-positive Pancreatic Cancer

NCT07383922 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Carbon Ions Radiation Therapy for Resectable or Borderline Resectable Pancreas Adenocarcinoma

NCT03822936 ·Status: TERMINATED ·Phase: PHASE2

Borderline Resectable Pancreatic Cancer Neoadjuvant Chemoradiotherapy Clinicaltrial-1

NCT03777462 ·Status: UNKNOWN ·Phase: PHASE2

A Multicenter Study of IBI343 Monotherapy Versus Placebo in Subjects With Previously Treated, Claudin (CLDN) 18.2-positive, Pancreatic Cancer(G-HOPE-002)

NCT07066098 ·Status: RECRUITING ·Phase: PHASE3

QL1706+Lenvatinib+AG Regimen as First-line Treatment for Advanced Metastatic Pancreatic Cancer

NCT07110064 ·Status: RECRUITING ·Phase: PHASE2

Study of Immune Checkpoint Inhibition With Radiation Therapy in Unresectable, Non-metastatic Pancreatic Cancer

NCT02868632 ·Status: WITHDRAWN ·Phase: PHASE1

Pembrolizumab Plus Chemotherapy in 1st Line Treatment of Pancreatic Cancer

NCT04447092 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Sintilimab Combined With Chemotherapy and Radiotherapy in Patients With Inoperable Pancreatic Cancer

NCT06050317 ·Status: RECRUITING ·Phase: PHASE2

Nivolumab With Ipilimumab Combined With TGFβ-15 Peptide Vaccine and Radiotherapy for Pancreatic Cancer

NCT05721846 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Clinical Study of Carbon Ion Radiotherapy for Pancreatic Cancer.

NCT06840067 ·Status: RECRUITING ·Phase: NA

Active Anti-diabetic Treatment Plus Chemotherapy for Pancreatic Cancer Related Diabetes

NCT07272109 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

First-in-human Study of the Theranostic Pair [68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G in Pancreatic Cancer

NCT04665947 ·Status: RECRUITING ·Phase: EARLY_PHASE1

Nimotuzumab Combined With Chemoradiotherapy in the Treatment of Unresectable Locally Advanced or Oligometastatic Pancreatic Cancer

NCT07386704 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2

Immunotherapy of CD8+NKG2D+ AKT Cell With Chemotherapy to Pancreatic Cancer

NCT02929797 ·Status: UNKNOWN ·Phase: EARLY_PHASE1

A Study of AGS-1C4D4 in Pancreatic Cancer Subjects Previously Treated in Protocol 2008002

NCT01608711 ·Status: COMPLETED ·Phase: PHASE2

Study of Nintedanib and Chemotherapy for Advanced Pancreatic Cancer

NCT02902484 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

First-line Regimen With QL1706 Plus Chemo ± Bev in PDAC Patients

NCT06313970 ·Status: RECRUITING ·Phase: PHASE2

Adebrelimab and Chidamide for Pancreatic Cancer

NCT06584227 ·Status: RECRUITING ·Phase: PHASE2

Clinical Research of ROBO1 Specific BiCAR-NK Cells on Patients With Pancreatic Cancer

NCT03941457 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

A Study to Compare QLS31905 and Chemotherapy With Placebo and Chemotherapy in Participants With Pancreatic Cancer

NCT07079228 ·Status: RECRUITING ·Phase: PHASE3

Gemcitabine/Capecitabine Followed by SBRT in Pancreatic Adenocarcinoma

NCT01360593 ·Status: COMPLETED ·Phase: PHASE2

Phase ǀ Study on Pancreatic Cancer Treated by CyberKnife

NCT02716207 ·Status: COMPLETED ·Phase: NA

Hyperpolarized 13C Pyruvate MRI for Treatment Response Assessment in Pancreatic Ductal Adenocarcinoma

NCT04565327 ·Status: TERMINATED ·Phase: PHASE2

A Study of AK104 With Chemotherapy as First-line Treatment in Patients With Advanced Pancreatic Cancer

NCT05859750 ·Status: RECRUITING ·Phase: PHASE2

Functional Magnetic Resonance Imaging of Pancreatic Cancer: a Feasibility and Reproducibility Study

NCT01995240 ·Status: COMPLETED ·Phase: NA